Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction - an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto i) and assessment of the safety of a new thrombolytic (assent 2) studies

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Barbash, G. I.
  • Birnbaum, Y.
  • Bogaerts, K.
  • Hudson, M.
  • Lesaffre, E.
  • Fu, Y. L.
  • Goodman, S.
  • Houbracken, K.
  • Munsters, K.
  • Granger, C. B.
  • Pieper, K.
  • Califf, R. M.
  • Topol, Eric
  • Van de Werf, F.

publication date

  • February 2001

journal

  • Circulation  Journal

subject areas

  • Aged
  • Angioplasty, Balloon, Coronary
  • Coronary Artery Bypass
  • Coronary Disease
  • Databases, Factual
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Multivariate Analysis
  • Myocardial Infarction
  • Retrospective Studies
  • Risk Factors
  • Secondary Prevention
  • Streptokinase
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator
  • Treatment Outcome
  • United States
scroll to property group menus

Research

keywords

  • myocardial infarction
  • reinfarction
  • revascularization
  • thrombolysis
  • trials
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0009-7322

PubMed ID

  • 11181469
scroll to property group menus

Additional Document Info

start page

  • 954

end page

  • 960

volume

  • 103

issue

  • 7

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support